Pacifica, CA, United States of America

Kristin Bowles

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 61(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2018 - 2020)
  • Pacifica, CA (US) (2016 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kristin Bowles: Innovator in Immune-Related Disease Treatments

Introduction

Kristin Bowles is a prominent inventor based in Pacifica, California, known for her significant contributions to the field of immunology. With a total of five patents to her name, she has made remarkable strides in developing innovative treatments for immune-related diseases and cancer.

Latest Patents

Among her latest patents, Kristin has developed compositions and methods for the treatment of immune-related diseases. This invention focuses on utilizing specific compositions for the diagnosis and treatment of these conditions. Additionally, she has created methods for treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors. This patent describes a combination treatment that includes a PD-1 axis binding antagonist and an agent that decreases or inhibits TIGIT expression and/or activity. These methods aim to enhance immunogenicity, particularly in increasing tumor immunogenicity for the treatment of cancer or chronic infections.

Career Highlights

Kristin currently works at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to collaborate with some of the brightest minds in the industry, further advancing her research and inventions.

Collaborations

Some of her notable coworkers include Dan L. Eaton and Jane Louise Grogan, who have contributed to her projects and research endeavors.

Conclusion

Kristin Bowles stands out as a dedicated inventor whose work is paving the way for new treatments in immunology and oncology. Her innovative patents reflect her commitment to improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…